CE: Opioid Use Disorder: Pathophysiology, Assessment, and Effective Interventions
- PMID: 32443123
- PMCID: PMC7446957
- DOI: 10.1097/01.NAJ.0000668736.80609.4e
CE: Opioid Use Disorder: Pathophysiology, Assessment, and Effective Interventions
Abstract
Opioid use disorder (OUD) is a chronic, relapsing disease. Genetic variability, dysregulated stress system response, and history of opioid experimentation or escalating exposure all contribute to the likelihood of developing OUD, which produces complex brain changes that make it difficult to stop opioid use. Understanding the neurobiology of OUD helps nurses anticipate the behaviors of patients with OUD and approach them with empathy. Here, the authors discuss the pathophysiology of OUD, available screening tools, medical treatments, and behavioral interventions that have demonstrated efficacy in reducing substance use.
Figures
References
-
- Bendix J (2018). Opioid policy fallout. Medical Economics, 10, 96 Retrieved June 18, 2019 https://www.medicaleconomics.com/business/opioid-policy-fallout
-
- Blanco C, Volkow N (2019) Management of opioid use disorder in the USA:present status and future directions. The Lancet,393(10182), 1760–1772. - PubMed
-
- Burke BL, Arkowitz H, & Menchola M (2003). The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. Journal of Consulting on Clinical Psychology, 71, 843–862. - PubMed
-
- Butelman E, Chen C, Fry R, Kimani R, Levran O, Ott J, Correa R, Kreek M (2018) Re-evaluation of the KMSK scales, rapid dimensional measures of self-exposure to specific drugs: gender specific features. Drug and Alcohol Dependence, 190, 179–87 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical